NCT06637956View on ClinicalTrials.gov

The Effect of Intranasally Administered Nitroglycerin on Hemodynamic Response to Laryngoscopy and Intubation Among Patients Undergoing Coronary Artery Bypass Grafting (CABG) Surgery

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

June 30, 2024

Study Completion Date

June 30, 2024

Conditions

Coronary Artery Bypass Grafting

Interventions

DRUG

Nitroglycerin (NTG)

Received 1 mg of nitroglycerin intranasally two minutes prior to laryngoscopy and intubation

Trial Locations (1)

Unknown

Department of Anesthesia, Rashid Latif Medical College, Lahore

All Listed Sponsors

lead

Muhammad Aamir Latif

OTHER

NCT06637956 - The Effect of Intranasally Administered Nitroglycerin on Hemodynamic Response to Laryngoscopy and Intubation Among Patients Undergoing Coronary Artery Bypass Grafting (CABG) Surgery | Biotech Hunter | Biotech Hunter